Showing results (1841-1850 of 21,137) with videos related to
Sort By:
Pageof 2,114
Cells|December 24, 2021
Pyroptosis: Mechanisms and Links with FibrosisZihao Song, Quan Gong, Jiawei GuoCells|December 24, 2021
Pleiotropic Effects of the Protease-Activated Receptor 1 (PAR1) Inhibitor, Vorapaxar, on Atherosclerosis and Vascular InflammationJulian Friebel, Eileen Moritz, Marco Witkowski, et al.Cells|December 24, 2021
Effect of High Static Magnetic Fields on Biological Activities and Iron Metabolism in MLO-Y4 Osteocyte-like CellsJiancheng Yang, Gejing Zhang, Qingmei Li, et al.Cells|December 24, 2021
Role of Mitochondrial Protein Import in Age-Related Neurodegenerative and Cardiovascular DiseasesAndrey Bogorodskiy, Ivan Okhrimenko, Dmitrii Burkatovskii, et al.Cells|December 24, 2021
Activating Transcription Factor 3 Protects against Restraint Stress-Induced Gastrointestinal Injury in MiceDun-Jie Chuang, Subhashree Pethaperumal, Bijaya Siwakoti, et al.Cells|December 24, 2021
Immunomodulatory Properties of Polysaccharides from the Coral Pseudopterogorgia americana in MacrophagesOleg V Chernikov, Hsiao-Wen Chiu, Lan-Hui Li, et al.Cells|December 24, 2021
Clever Experimental Designs: Shortcuts for Better iPSC DifferentiationRyota Yasui, Keisuke Sekine, Hideki TaniguchiCells|December 24, 2021
Emerging Molecular Dependencies of Mutant EGFR-Driven Non-Small Cell Lung CancerDylan A Farnsworth, Yankuan T Chen, Georgia de Rappard Yuswack, et al.Cells|December 24, 2021
EGFR-D770>GY and Other Rare EGFR Exon 20 Insertion Mutations with a G770 Equivalence Are Sensitive to Dacomitinib or Afatinib and Responsive to EGFR Exon 20 Insertion Mutant-Active Inhibitors in Preclinical Models and Clinical ScenariosIkei S Kobayashi, Hollis Viray, Deepa Rangachari, et al.Pageof 2,114